✦ LIBER ✦
496 Long-Term Safety of An Anti-TNF Drug By Duration of Exposure Compared to Non-Anti-TNF Exposed Patients with Crohn's Disease: Novel Data from the Certolizumab Pegol Development Program
✍ Scribed by Gary R. Lichtenstein; Jean-Frédéric Colombel; Ralph Bloomfield; William J. Sandborn
- Book ID
- 119428195
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 69 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.